- Language: English
- 176 Pages
- Published: November 2013
- Region: Global
Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015
- Published: June 2013
- Region: Global
- 370 Pages
- Axis Research Mind
Global Polymerase Chain Reaction (PCR) Market to reach US$27.4 billion by 2015 on positive growth prospects of PCR equipments and reagents segment
The global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more than 50% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 14.8%, to worth around US$1.3 billion in 2015.
Based on the classification by products/tools, PCR Reagents are expected to be fastest growing market with a CAGR of 14.6%. PCR Consumables and PCR Machines are expected grow with a CAGR of 14.2% and 13.1% respectively.
The report “Polymerase Chain Reaction (PCR): Products/Tools – A Global Market Watch, 2009-2015” reviews the latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.
The report primarily focuses on:
- Emerging market trends
- Advancements in the technological space
- Market demand of the segments (by-region)
- Key growth areas and market size
- Key competitor’s Edge
The analysis primarily deals with major PCR product/tools market. Further, the subdivided categories include:
- PCR Machines
- PCR Reagents
- PCR Consumables
- Other (Software, Pipetting Robot & etc.,)
The period considered for the PCR market analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (France, Germany, United Kingdom, Italy, Spain and Rest of Europe), Asia- Pacific (Japan, China, India, Korea and Rest of Asia-Pacific), Latin America (Brazil, Columbia, Argentina and Rest of Latin America) and Rest of the World. Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 850 leading market players are identified and 49 key companies that project improved market activities in the near future are profiled. The report consists of 115 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
The broad ‘life science’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the PCR industry, even during the recession years, confirms the positive growth prospects going ahead. Among the major developments in the recent years, gene amplification technology indicates the highest potential growth. Molecular diagnostics and the Human Genome Project (HGP) are two of the main drivers that contribute to the growth of gene amplification technology. It covers all segments such as drug discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth. Among the PCR types, q-PCR is expected witness the largest CAGR during 2009-2015.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the PCR industry. SHOW LESS READ MORE >
- Abbott Laboratories
- Agilent Technologies
- BD Biosciences
- BioRad Laboratories
- Complete Genomics
- Cytocell Ltd
- Dna Landmarks
- Dnavision SA
- Epicentre® Biotechnologies
- Eppendorf AG
- GE Healthcare (Life Sciences)
- HY LABORATORIES
- Hokkaido System Science Co.
- Ocimum Biosolutions
- Roche Diagnostics
- Shimadzu Biotech
... and many more